Dentistry and Oral Surgery

Frohberg U, Triplett G. The influence of implant material, design, and surface topographies on osseointegration of dental implants [German]. Ästhetische Zahnmedizin 2006;9:32–41.

Goncalves JR, Buschang PH, Goncalves DG, Wolford LM. Postsurgical stability of oropharyngeal airway changes following counter-clockwise maxillo-mandibular advancement surgery. J Oral Maxillofac Surg 2006;64(5):755–762.

Muto T, Akizuki K, Wolford LM. Simplified technique to change the endotracheal tube from nasal to oral to facilitate orthognathic and nasal surgery. J Oral Maxillofac Surg 2006;64(8):1310–1312.

Wolford LM. Factors to consider in joint prosthesis systems. Proc (Bayl Univ Med Cent) 2006;19(3):232–238.

Zafiropoulos G, Beaumont C, Willershausen D, Frohberg U, Kasaj A. Unspecific plaque control with instrumentation [German]. Stomatologie 2006;103:55–62.

Zafiropoulos G, Kasaj A, Beaumont C, Willershausen D, Frohberg U. The use of antibiotics in the periodontal treatment. The specific plaque control [German]. Stomatologie 2006;103:39–47.

Zafiropoulos G, Weiss O, Willershausen D, Beaumont C, Frohberg U, Kasaj A. Special diagnostic methods related to aggressive periodontitis [German]. ZWR 2006;115:34–38.

Dermatology

Abramovits W, Boguniewicz M; Adult Atopiclair Study Group. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults. J Drugs Dermatol 2006;5(3):236–244.

Abramovits W, Hung P, Tong KB. Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis. Am J Clin Dermatol 2006;7(4):213–222.

Abramovits W, Losornio M. Failure of two TNF-alpha blockers to influence the course of alopecia areata. Skinmed 2006;5(4):177–181.

Abramovits W, Losornio M, Marais G, Perlmutter A. Cutaneous cryosurgery. Dermatol Nurs 2006;18(5):456–459.

Abramovits W, Perlmutter A. MimyX cream. Skinmed 2006;5(1):29–30.

Abramovits W, Perlmutter A. Steroids versus other immune modulators in the management of allergic dermatoses. Curr Opin Allergy Clin Immunol 2006;6(5):345–354.

Abramovits W, Perlmutter A, Gupta AK. Taclonex (calcipotriene 0.005% and betamethasone dipropionate 0.064%) ointment. Skinmed 2006;5(3):136–138.

Carey W, Glazer S, Gottlieb AB, Lebwohl M, Leonardi C, Menter A, Papp K, Rundle AC, Toth D. Relapse, rebound, and psoriasis adverse events: an advisory group report. J Am Acad Dermatol 2006;54(4 Suppl 1):S171-S181.

Cather JC. Bumps on the hand. Proc (Bayl Univ Med Cent) 2006;19(3):277–278.

Cather JC. Papule on the dorsal foot. Proc (Bayl Univ Med Cent) 2006;19(2):151–152.

Cather JC. Pruritic eruption on the anterior shins. Proc (Bayl Univ Med Cent) 2006;19(4):409–410.

Gordon KB, Langley RG, Leonardi C, Toth D, Menter MA, Kang S, Heffernan M, Miller B, Hamlin R, Lim L, Zhong J, Hoffman R, Okun MM. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study. J Am Acad Dermatol 2006;55(4):598–606.

Gupta AK, Abramovits W, Gover MD. Clobex (clobetasol propionate) spray, 0.05%. Skinmed 2006;5(4):184–185.

Gupta AK, Gover MD, Abramovits W, Perlmutter A. Solodyn (minocycline HCl, USP) extended-release tablets. Skinmed 2006;5(6):291–292.

Leonardi CL, Toth D, Cather JC, Langley RG, Werther W, Compton P, Kwon P, Wetherill G, Curtin F, Menter A. A review of malignancies observed during efalizumab (Raptiva) clinical trials for plaque psoriasis. Dermatology 2006;213(3):204–214.

Li LY, Brimhall AK, Menter A. Systemic therapy for moderate-to-severe psorias Expert Rev Dermatol 2006;1(1):77–92.

Lowe N, Horwitz S, Tanghetti E, Draelos Z, Menter A. Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized study. J Cosmet Laser Ther 2006;8(3):121–127.

McQuade J, Cather JC. Fever and malaise associated with a painful papule on the ankle. Proc (Bayl Univ Med Cent) 2006;19(1):49–51.

Mease PJ, Menter MA. Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective. J Am Acad Dermatol 2006;54(4):685–704.

Menter A. The Koo-Menter Psoriasis Instrument for identifying candidate patients for systemic therapy. In Koo JYM, Lebwohl MG, Lee CS, eds. Mild-to-Moderate Psoriasis. New York: Informa Healthcare, 2006:9–28.

Menter A. Recent advances in psoriasis therapy and the work of the International Psoriasis Council. US Derm Review 2006;1:23–27.

Menter A. Summary of therapeutic options for mild-to-moderate psoriasis. In Koo JYM, Lebwohl MG, Lee CS, eds. Mild-to-Moderate Psoriasis. New York: Informa Healthcare, 2006:243–261.

Menter A, Cather JC, Baker D, Farber HF, Lebwohl M, Darif M. The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis. J Am Acad Dermatol 2006;54(1):61–63.

Menter A, Leonardi CL, Sterry W, Bos JD, Papp KA. Long-term management of plaque psoriasis with continuous efalizumab therapy. J Am Acad Dermatol 2006;54(4 Suppl 1):S182–S188.

Papp KA, Bressinck R, Fretzin S, Goffe B, Kempers S, Gordon KB, Caro I, Walicke PA, Wang X, Menter A; Efalizumab Study Group. Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb, randomized, controlled trial. Int J Dermatol 2006;45(5):605–614.

Perlmutter A, Abramovits W, Gupta AK. Oracea (doxycycline monohydrate). Skinmed 2006;5(5):238–240.

Tanghetti E, Abramovits W, Solomon B, Loven K, Shalita A. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial. J Drugs Dermatol 2006;5(3):256–261.

Whiting DA. Androgenetic alopecia: diagnosis and treatment. Kosmetische Medizin 2006;5/6: 220–223.

Whiting DA , Dy LC . Office diagnosis of hair shaft defects. Se min Cutan Med Surg 2006;25(1):24–34.